Stock BIOC GLAXOSMITHKLINE S.A.E
Add to a list
To use this feature you must be a member
Log inSign up

Company GlaxoSmithKline S.A.E

Equities

BIOC

EGS38171C012

Pharmaceuticals

End-of-day quote Egyptian Exchange
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
32.32 EGP +2.41% Intraday chart for GlaxoSmithKline S.A.E -0.15% -9.09%
Mar. 04 GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

GlaxoSmithKline Egypt S.A.E. specializes in the development, manufacture and marketing of medicines. Their products are for the treatment of diabetes, asthma, cancer, hepatic viruses, infections, allergies and gastro-intestinal and cardiovascular diseases.

Sales per Business

EGP in Million2017Weight2018Weight Delta
Medical
85.1 %
1,271 88.5 % 1,381 85.1 % +8.68%
Consumer Care
14.9 %
165 11.5 % 242 14.9 % +46.62%

Sales per region

EGP in Million2017Weight2018Weight Delta
Egypt
100.0 %
1,436 100.0 % 1,623 100.0 % +13.04%

Managers

Managers TitleAgeSince
Ashraf Mohammed Ibrahim Mansour CHM
 Chairman - -
Ahmed Ramadhan Rashad IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Sherine El-Ansari BRD
 Director/Board Member - -
Ashraf Mohammed Ibrahim Mansour CHM
 Chairman - -
Munir Ghabour Hanna BRD
 Director/Board Member - -
Omnia Saad Abdel Rahman Kelig BRD
 Director/Board Member - -
Henry Antaki BRD
 Director/Board Member - -
Karim Mohammed Hamdi BRD
 Director/Board Member - -
Ahmed Abdel Hamid Fahmi Khattab BRD
 Director/Board Member - -
Najib Shabei BRD
 Director/Board Member - -
Laila Danial Shakir Bolis BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 83,514,200 2,434,272 ( 2.915 %) 0 2.915 %

Shareholders

NameEquities%Valuation
GSK PLC
91.20 %
76,161,378 91.20 % 48 M £
QNB ALAHLI S.A.E
5.889 %
4,918,550 5.889 % 3 M £
Dimensional Fund Advisors Ltd.
0.0783 %
65,403 0.0783 % 41 435 £

Company contact information

GlaxoSmithKline (Egypt)

Boomerang Building 1st Section City Centre, No. 46

11835, Cairo

+

http://www.gsk.com/en-gb/contact-us/worldwide/egypt/
address GlaxoSmithKline S.A.E(BIOC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
GLAXOSMITHKLINE S.A.E Stock GlaxoSmithKline S.A.E
-9.09% 56.35M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+24.35% 653B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+25.67% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.95% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.96% 233B
NOVARTIS AG Stock Novartis AG
+5.10% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 193B
AMGEN INC. Stock Amgen Inc.
-6.47% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BIOC Stock
  4. Company GlaxoSmithKline S.A.E